Studies suggest that physiological modifications in the cerebral vasculature may contribute to AD pathology and cognitive decline prior to clinically detectable changes in amyloid beta (A) and tau, diagnostic biomarkers of AD (Sweeney et al., 2018, 2019)
BPC 157 10 g/kg, intraperitoneally or per-orally, was given with l-NAME (5 mg/kg intraperitoneally) and/or L-arginine (100 mg/kg intraperitoneally) and it maintained its original beneficial effect
MOTS-c Mitochondrial-derived peptide with obesity and metabolic research interest
Key findings include enhanced phosphorylation of Src, Caveolin-1, and eNOS, with the vasodilation effect being abolished by nitric oxide inhibitors
We conducted linear regression analysis of the Pathway_ranks over the past 10 years of each pathway, and pathways exhibiting a statistically significant upward trend ( P 0.5